MK-677 (Ibutamoren): Oral GH Secretagogue Complete Guide

MK-677 (ibutamoren mesylate) is a non-peptide, orally active ghrelin receptor agonist that produces sustained elevation of growth hormone and IGF-1 levels from a single daily oral dose. Unlike injectable peptide secretagogues that must be reconstituted and injected multiple times daily, MK-677 is taken as a capsule and has a 24-hour half-life — making it one of the most practically accessible GH-elevating compounds. It was developed by Merck Research Laboratories and has been through multiple clinical trials, though it never received FDA approval despite promising results.

Mechanism of Action

MK-677 acts as a full agonist at the GHSR-1a (ghrelin receptor), the same receptor targeted by GHRP-6 and ipamorelin. However, while those peptides have half-lives of 30–60 minutes, MK-677's non-peptide structure and high oral bioavailability give it a plasma half-life of approximately 24 hours.

This sustained GHSR-1a activation produces:

• Continuous elevation of GH secretion (both amplitude and frequency of pulses)
• Sustained IGF-1 elevation (typically 40–60% above baseline)
• Increased appetite (via hypothalamic ghrelin receptor activation)
• Improved sleep architecture (increased slow-wave sleep)

Unlike direct GH injection, MK-677 stimulates endogenous GH production and preserves the natural feedback axis — though with chronic use, some degree of somatostatin tone increases as a homeostatic response.

Clinical Trials

MK-677 has one of the most extensive clinical trial datasets of any research peptide:

1998 NEJM study (Cummings et al.): 32 obese men given MK-677 25 mg/day for 8 weeks showed significantly elevated 24-hour GH and IGF-1 levels, with increased fat-free mass and reduced fat mass. Nitrogen balance improved, and the compound was well-tolerated.

2008 study in older adults (Nass et al.): 65 adults aged 60–81 received MK-677 25 mg/day for 12 months. GH and IGF-1 rose significantly. Fat-free mass increased; bone mineral density improved. However, two adverse events — increased fasting glucose and insulin resistance — were notable, though not severe.

Cachexia trial: A 2-year randomized controlled trial in hip fracture patients showed MK-677 25 mg/day improved stair-climbing power, muscle strength, and functional capacity compared to placebo.

Sleep study (Copinschi et al.): MK-677 significantly increased slow-wave sleep duration and sleep efficiency — an effect maintained over months without tolerance developing to the sleep benefit.

Dosage

Standard dose: 25 mg orally once daily, before sleep Lower dose: 10–15 mg/day for those sensitive to appetite stimulation or water retention Higher dose: Some protocols use 50 mg/day, though the GH/IGF-1 response appears to plateau around 25 mg

Timing: Bedtime dosing is preferred because:

1. It amplifies the natural GH pulse that occurs during slow-wave sleep
2. Appetite stimulation during sleep hours is less disruptive than daytime hunger
3. Water retention (which peaks 4–6 hours post-dose) occurs during sleep when it is less noticeable

Cycle length: MK-677 is commonly cycled for 3–6 months, followed by a break of 1–2 months. Some users continue for 12 months given the clinical trial data supporting longer use.

Expected Effects

Weeks 1–2: Improved sleep quality; increased hunger; mild water retention (can cause 2–5 lbs of scale weight gain initially)

Weeks 3–8: Progressive fat loss (primarily visceral), improved muscle fullness, better recovery from training

Weeks 8–24: Continued body composition improvement; IGF-1 elevation measurable on blood tests; improved skin quality and collagen density

Side Effects

Water retention: The most common side effect. Typically peaks in the first 2–4 weeks and diminishes as the body adapts. Lower doses (10–15 mg) significantly reduce this effect.

Increased hunger: A direct ghrelin receptor effect. Intense hunger, particularly in the evening, can make caloric control difficult for fat loss goals.

Insulin resistance: Clinically documented in multiple trials. MK-677 reduces insulin sensitivity, which can elevate fasting glucose in susceptible individuals. This is the most significant safety concern with long-term use.

Fatigue/lethargy: Some users report daytime drowsiness, particularly during the first few weeks. Taking the dose at night mitigates this.

Tingling/numbness: GH-related carpal tunnel-like symptoms at higher doses.

Regulatory Status

MK-677 is not FDA-approved for any indication. It is commonly sold as a research chemical. Importantly, MK-677 is NOT classified as a SARM (selective androgen receptor modulator) despite being frequently categorized alongside SARMs in the supplement market. It has a completely different mechanism. However, the FDA has taken action against companies selling it as a dietary supplement.

WADA classifies MK-677 as a prohibited substance (as a GH secretagogue).

FAQ

Can MK-677 cause diabetes? MK-677 reduces insulin sensitivity in a dose-dependent manner. In the 2008 12-month trial, two of 65 subjects developed clinically significant fasting glucose elevation. Individuals with pre-existing insulin resistance, metabolic syndrome, or family history of type 2 diabetes should use MK-677 cautiously and monitor fasting glucose and HbA1c.

Does MK-677 work as well as injectable HGH? MK-677 typically elevates IGF-1 by 40–60% above baseline. This is less than what supraphysiological HGH injections produce, but comparable to the effects of moderate GH optimization in individuals with age-related GH decline. The advantage is oral administration and a more physiological stimulation pattern.

Will tolerance develop to MK-677? Clinical trials show sustained GH and IGF-1 elevation over 12 months without significant tolerance to these hormonal effects. The appetite-stimulating effect appears to diminish with chronic use in some users, likely due to receptor adaptation.

Related Articles

• Afamelanotide: FDA-Approved Melanocyte Peptide
• AOD-9604: HGH Fragment for Fat Loss
• Argireline: The Topical Peptide Alternative to Botox?
• Bacteriostatic Water for Peptides: Why It Matters and How to Use It
• Best Peptide Stacks for Recovery, Fat Loss, and Longevity

Track your supplements in Optimize.